Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares (2020 - 2024)

Eton Pharmaceuticals (ETON) has disclosed Treasury Shares for 4 consecutive years, with $226068.0 as the latest value for Q4 2024.

  • Quarterly Treasury Shares fell 17.55% to $226068.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $226068.0 through Dec 2024, down 17.55% year-over-year, with the annual reading at $226068.0 for FY2024, 17.55% down from the prior year.
  • Treasury Shares hit $226068.0 in Q4 2024 for Eton Pharmaceuticals, down from $274204.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $369606.0 in Q3 2022 to a low of $7595.0 in Q4 2020.
  • Historically, Treasury Shares has averaged $249415.8 across 4 years, with a median of $274204.0 in 2023.
  • Biggest five-year swings in Treasury Shares: fell 25.81% in 2023 and later dropped 17.55% in 2024.
  • Year by year, Treasury Shares stood at $7595.0 in 2020, then soared by 4766.44% to $369606.0 in 2022, then dropped by 25.81% to $274204.0 in 2023, then decreased by 17.55% to $226068.0 in 2024.
  • Business Quant data shows Treasury Shares for ETON at $226068.0 in Q4 2024, $274204.0 in Q4 2023, and $369606.0 in Q4 2022.